English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A new class of tamoxifen analogues, using McMurry reaction conditions, is described. The scheme involved the conversion of ketoprofen ( 6 ) into amide derivatives  7  and  8 , by coupling with  N 1 ,N 1-substituted propan-1,3-diamine derivatives in the presence DIC and HOB. Treatment of  7  and  8  with various ketones under McMurry reaction conditions afforded the tamoxifen analogues  9–16 . All the analogues were screened  in vitro  for their aromatase inhibitory and antiproliferative activity against MCF-7 breast cancer cells. Compounds  10, 11  and  12  showed a potent activity against MCF-7 cell lines breast cancer with IC 50  values of 0.070, 0.042 and 0.077 µM of selectivity index (SI) 3.0, 2.5 and 2.6, respectively. Further,  12  exhibited potent activity against estrogen receptor (14.7 ± 2.4 nM), while compound  10  was the most active analogues against aromatase with IC50 of (0.070 nM). Furthermore, all new compounds were docked into human placental aromatase enzyme and estrogen receptor and showed very good correlations with experimental IC50. Therefore, we can consider these designed compounds as starting scaffold to design an efficient drug against estrogen receptor and aromatase. Communicated by Ramaswamy H. Sarma

New tamoxifen analogs for breast cancer therapy: synthesis, aromatase inhibition and in silico studies